News Focus
News Focus
Followers 22
Posts 2254
Boards Moderated 0
Alias Born 06/08/2017

Re: Jack2479 post# 428071

Monday, 12/20/2021 5:56:37 PM

Monday, December 20, 2021 5:56:37 PM

Post# of 817894
That it is safe with little or no side effects - I think we already know this.

It breaks new ground in terms of efficacy, it’s personalised - The evidence certainly points that way. And we know it is as personalized as it gets in a very heterogeneous disease regardless of primary tumor location.

Scaleable - I have faith on this with Flask works. This is already magnitudes greater than Provenge in its suspected efficacy and utility/required inputs. 1 leuka vs multipe to make 3 years worth of vaccines. Multiple patient specific antigens baked at just the right temp.

I suspect we will have a good day tomorrow. Someone let Bigger know.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News